You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Orto+ will be market and distribute Todos' TM-B2 test for breast cancer screening in Romania and Austria. The test is CE marked.
The test is designed to measure levels of seven auto-antibodies to tumor-associated antigens and can detect all forms of lung cancer at any stage.
Under the deal, Theradiag will have access to Immunodiagnostic's IDS-i10 automation system, and Immunodiagnostic will distribute Theradiag tests in 33 countries.
Addenbrooke' Hospital will manage and facilitate the fulfillment orders of the firm's PredictSure IBD orders, as well as receive and process all samples.
Under the agreement, Menarini will immediately begin distributing Curetis' PCR-based system in Germany, France, Benelux, the UK, and Switzerland.
The partners inked a licensing deal to market and distribute TGen's DeepChek-TB as a compact, portable, and affordable diagnostic model for physician use.
The agreement gives Inside Diagnósticos the right to sell Sienna’s hTERT test to pathology labs in Brazil for use as an adjunct to urine cytology.
Hardy Dx will distribute EliTechGroup's Mycofast US for detecting, enumerating, and identifying genital Mycoplasma hominis and Ureaplasma urealyticum.
Life Genomics will distribute Luxia's 1test1 test in Sweden, Denmark, Finland, Iceland, and Norway. The test leverages sequencing technology to analyze the 16s RNA gene.
The Australian maker of multiplexed molecular diagnostics tests has now partnered with distributors in Germany, Austria, Sweden, and Turkey.